Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations Asean Press Releases the WCLC January 28, 20210 Exciting New Research to be Presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer’s Presidential Symposium SINGAPORE, Jan. 28, 2021 (GLOBE NEWSWIRE) — In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small cell lung cancer (NSCLC) […]
Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer Asean Press Releases the WCLC September 24, 20180 TORONTO, Sept. 23, 2018 (GLOBE NEWSWIRE) — Patients, survivors and advocates joined researchers and physicians from across the globe to discuss the future of lung cancer at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada. The conference’s first press briefing highlighted the record-breaking […]
World Conference on Lung Cancer Monday Press Conference: Dangers of Smoking and Lung Cancer Intervention Research Asean General the WCLC October 16, 20170 YOKOHAMA, Japan, Oct. 16, 2017 (GLOBE NEWSWIRE) — At today’s press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC), the world’s preeminent lung cancer researchers provided new insights on CT screening, smoking cessation and mesothelioma. The discussion focused in particular on the conference’s host […]
